{"as_of":"2026-08-10T03:34:00Z","caps":{"database_statements":6,"inbound":100,"outbound":100},"context_digest":"sha256:d2abd239df89459d8aec9b1e9ac094d48a5c3c828db4947f5b46af0473ccf2e4","coverage":[{"denominator":7,"lane":"reference_resolution","note":"Typed states for the displayed outbound observations.","records_observed":7,"source":"paper_references, paper_reference_links","source_observed_at":"2026-08-07T21:12:20.571688Z","state":"measured"},{"denominator":7,"lane":"standing_notices","note":"One-hop event checks from named stored sources.","records_observed":7,"source":"scholarly_work_events, retraction_status_cache","source_observed_at":"2026-08-09T06:31:02.800959+00:00","state":"measured"},{"denominator":0,"lane":"inbound_itemization","note":"Pith citing papers itemized under the disclosed page cap.","records_observed":0,"source":"paper_references, paper_reference_links","source_observed_at":null,"state":"measured"},{"denominator":1,"lane":"external_citation_measurements","note":"A source-named dated measurement, never combined with another source.","records_observed":0,"source":"cited_works","source_observed_at":null,"state":"measured"}],"external_citation_measurements":[],"inbound":[],"links":{"evidence":"/evidence","html":"/paper/2502.09527/citation-record","integrity":"/paper/2502.09527/integrity","json":"/paper/2502.09527/citation-record.json","paper":"/paper/2502.09527"},"outbound":[{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":"10.1186/s13362-021-00099-3","metadata_source":"doi_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-07T21:12:20.619144Z","title":"Computational Statistics, (2nd ed.)","venue":null,"work_id":"108d19dd-30f6-4476-b807-dd5e7da26aed","year":null},"citing_paper":{"arxiv_id":"2502.09527","last_updated":"2025-02-13T17:39:28Z","snapshot_observed_at":"2026-08-08T20:35:27.412544Z","submitted_at":"2025-02-13T17:39:28Z","title":"Project portfolio planning in the pharmaceutical industry -- strategic objectives and quantitative optimization","version":1},"reference_index":3,"source":"pdf_text","source_observed_at":"2026-08-07T21:12:20.559466Z"},"links":{"citing_paper":"/paper/2502.09527"},"observation_digest":"sha256:df352a6b38b95774ba85caa74ed2098aba69137f0668dca01cc6acea829c5220","observation_id":"32da2e34-57e0-4598-8a55-b47b55eb6617","resolution":{"observed_at":"2026-08-07T21:12:20.622733Z","resolver_source":"doi","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-09T06:31:02.800959+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-09T06:31:02.800959+00:00","source":"crossref"},{"observed_at":"2026-08-09T06:30:57.326959+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":"10.1002/pst.2316","metadata_source":"doi_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-07T21:12:20.595393Z","title":"Replenishing the pipeline: A quantitative approach to optimising the sourcing of new projects","venue":null,"work_id":"dfcf8b33-c51c-469a-96a2-e17d539d35bf","year":2023},"citing_paper":{"arxiv_id":"2502.09527","last_updated":"2025-02-13T17:39:28Z","snapshot_observed_at":"2026-08-08T20:35:27.412544Z","submitted_at":"2025-02-13T17:39:28Z","title":"Project portfolio planning in the pharmaceutical industry -- strategic objectives and quantitative optimization","version":1},"reference_index":296,"source":"pdf_text","source_observed_at":"2026-08-07T21:12:20.571688Z"},"links":{"citing_paper":"/paper/2502.09527"},"observation_digest":"sha256:7ff3aa3c059b803b5dff10f5ae7929e34627ca8a6f4991698cce3d6bc7395479","observation_id":"e66e94f4-b8ac-489d-a186-c20ed92dcc3d","resolution":{"observed_at":"2026-08-07T21:12:20.601164Z","resolver_source":"doi","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-09T06:31:02.800959+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-09T06:31:02.800959+00:00","source":"crossref"},{"observed_at":"2026-08-09T06:30:57.326959+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-07T21:12:20.564508Z","title":"Graham E, Jaki T, Harbron C","venue":null,"work_id":null,"year":2020},"citing_paper":{"arxiv_id":"2502.09527","last_updated":"2025-02-13T17:39:28Z","snapshot_observed_at":"2026-08-08T20:35:27.412544Z","submitted_at":"2025-02-13T17:39:28Z","title":"Project portfolio planning in the pharmaceutical industry -- strategic objectives and quantitative optimization","version":1},"reference_index":2013,"source":"pdf_text","source_observed_at":"2026-08-07T21:12:20.564508Z"},"links":{"citing_paper":"/paper/2502.09527"},"observation_digest":"sha256:4bf467e46ff708c6ce3907885434655c10cc4483cdb1fdbbd9ade1224d79e510","observation_id":"3f2bd2ed-951d-4c5b-94e0-b604111fb257","resolution":{"observed_at":"2026-08-07T21:12:20.564508Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":"10.1007/978-3-319-09075-7","metadata_source":"openalex","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-09T00:03:45.533247Z","title":"doi:10.1007/978-3-319-09075-7 Baird LG, et al","venue":null,"work_id":"c646b0fb-4983-4f5c-898c-3ab152a29418","year":2014},"citing_paper":{"arxiv_id":"2502.09527","last_updated":"2025-02-13T17:39:28Z","snapshot_observed_at":"2026-08-08T20:35:27.412544Z","submitted_at":"2025-02-13T17:39:28Z","title":"Project portfolio planning in the pharmaceutical industry -- strategic objectives and quantitative optimization","version":1},"reference_index":2015,"source":"pdf_text","source_observed_at":"2026-08-07T21:12:20.549253Z"},"links":{"citing_paper":"/paper/2502.09527"},"observation_digest":"sha256:e66ad2ac7339ea2e7750b8b70cae1ed1bfb0d0b52455a8a9b3d9b69dd58576ce","observation_id":"85951109-e77a-4004-8873-1a6d0c0103a1","resolution":{"observed_at":"2026-08-07T21:12:20.643569Z","resolver_source":"doi","status":"verified_exact"},"standing_notice":{"events":[{"edge_observation":{"observed_at":"2026-08-08T00:17:56.781705+00:00","source":"paper_reference_links","state":"open"},"event_date":"2014-12-09","event_type":"correction","notice_doi":"10.1007/978-3-319-09075-7_12","provenance":{"observed_at":"2026-07-11T03:15:10.817583+00:00","source":"crossref","source_record_id":"10.1007/978-3-319-09075-7_12->10.1007/978-3-319-09075-7:correction"}}],"reason":null,"source_receipts":[{"observed_at":"2026-08-09T06:31:02.800959+00:00","source":"crossref"},{"observed_at":"2026-08-09T06:30:57.326959+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":"10.1038/clpt.2010.247","metadata_source":"doi_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-07T21:12:20.629073Z","title":"Innovation in the pharmaceutical industry: New estimates of R&D costs, Journal of Health Econonmy, 2016, 47, 20–33","venue":null,"work_id":"3e61a5d7-80fc-473d-ab01-e96c358f2c74","year":2016},"citing_paper":{"arxiv_id":"2502.09527","last_updated":"2025-02-13T17:39:28Z","snapshot_observed_at":"2026-08-08T20:35:27.412544Z","submitted_at":"2025-02-13T17:39:28Z","title":"Project portfolio planning in the pharmaceutical industry -- strategic objectives and quantitative optimization","version":1},"reference_index":2019,"source":"pdf_text","source_observed_at":"2026-08-07T21:12:20.553157Z"},"links":{"citing_paper":"/paper/2502.09527"},"observation_digest":"sha256:75af98464841e6cf09529303d5e9c220b5908f9489ca2dc7db3819cb1e11ce37","observation_id":"2a9af96c-22d5-468b-a932-3056b168a9e7","resolution":{"observed_at":"2026-08-07T21:12:20.634112Z","resolver_source":"doi","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-09T06:31:02.800959+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-09T06:31:02.800959+00:00","source":"crossref"},{"observed_at":"2026-08-09T06:30:57.326959+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":"10.2139/ssrn.2675317","metadata_source":"doi_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-07T21:12:20.609320Z","title":"Leisinger KM","venue":null,"work_id":"85c703be-5659-4472-9fa9-e74db477a8f6","year":2005},"citing_paper":{"arxiv_id":"2502.09527","last_updated":"2025-02-13T17:39:28Z","snapshot_observed_at":"2026-08-08T20:35:27.412544Z","submitted_at":"2025-02-13T17:39:28Z","title":"Project portfolio planning in the pharmaceutical industry -- strategic objectives and quantitative optimization","version":1},"reference_index":2022,"source":"pdf_text","source_observed_at":"2026-08-07T21:12:20.568160Z"},"links":{"citing_paper":"/paper/2502.09527"},"observation_digest":"sha256:fbf7d8518121dbbd170377cc8495cd20d46d480a22f927bbcb7715f8e36a4832","observation_id":"a68bc633-5d98-4f62-9787-4e4c14e913dd","resolution":{"observed_at":"2026-08-07T21:12:20.612777Z","resolver_source":"doi","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-09T06:31:02.800959+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-09T06:31:02.800959+00:00","source":"crossref"},{"observed_at":"2026-08-09T06:30:57.326959+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-07T21:12:20.730444Z","title":"Pharmaceutical portfolio optimization under cost uncertainty via chance constrained-type method","venue":null,"work_id":"a1c53717-4c7f-4ec6-9676-d41f0b337733","year":2021},"citing_paper":{"arxiv_id":"2502.09527","last_updated":"2025-02-13T17:39:28Z","snapshot_observed_at":"2026-08-08T20:35:27.412544Z","submitted_at":"2025-02-13T17:39:28Z","title":"Project portfolio planning in the pharmaceutical industry -- strategic objectives and quantitative optimization","version":1},"reference_index":2169,"source":"pdf_text","source_observed_at":"2026-08-07T21:12:20.556467Z"},"links":{"citing_paper":"/paper/2502.09527"},"observation_digest":"sha256:98eaf52da31560d478dbc497b7a99809e2f7a6c1dccc972eff207cf4d6fe69d8","observation_id":"f1d3587c-5665-4a34-bb3d-347a2b8b99a6","resolution":{"observed_at":"2026-08-07T21:12:20.734446Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-09T06:31:02.800959+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-09T06:31:02.800959+00:00","source":"crossref"},{"observed_at":"2026-08-09T06:30:57.326959+00:00","source":"retraction_watch"}],"state":"measured"}}],"paper":{"arxiv_id":"2502.09527","last_updated":"2025-02-13T17:39:28Z","latest_version":1,"primary_category":"stat.AP","snapshot_observed_at":"2026-08-08T20:35:27.412544Z","submitted_at":"2025-02-13T17:39:28Z","title":"Project portfolio planning in the pharmaceutical industry -- strategic objectives and quantitative optimization"},"reference_resolution":{"displayed":7,"state_counts":{"malformed_identifier":0,"metadata_mismatch":0,"parse_uncertain":0,"unresolved":1,"verified_exact":5,"verified_fuzzy":1},"total_outbound_references":7},"refusal":"A citation records a reference. It does not transfer a finding from one paper to another.","schema":"pith.paper-citation-record.v1","standing_sources":[{"observed_at":"2026-08-09T06:31:02.800959+00:00","source":"crossref"},{"observed_at":"2026-08-09T06:30:57.326959+00:00","source":"retraction_watch"}],"thesis":"As of 10 August 2026, this Paper Citation Record lists 7 of 7 outbound references and 0 inbound Pith citation observations for arXiv:2502.09527."}